Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

Our Business Model

Key to our Business Model

Reporting Segments

Dechra Activity

Customers

Partners

PRODUCT DEVELOPMENT AND REGULATORY AFFAIRS

Provides products for the Group through in-house development of novel and generic pharmaceutical products, and specialist branded pet diets. Further products are acquired through in-licensing and marketing contracts with third party suppliers

EUROPEAN PHARMACEUTICALS

Dechra Manufacturing

Manufactures the majority of our own branded pharmaceutical products which are marketed through DVP EU and DVP US. Approximately 40% of manufacturing revenues are from third party toll manufacturing

DVP EU Sales and Marketing and Technical Support

Markets and sells our branded veterinary products within 13 European countries and manages the relationships with our worldwide marketing partners

US PHARMACEUTICALS

DVP US Sales and Marketing and Technical Support

Markets and sells our own veterinary products across the USA and distributes a number of our dermatological products to Export Partners worldwide

Third Party
Pharmaceutical Companies

Export Partners

Veterinary Wholesalers
and Distributors

SERVICES

NVS Veterinary
Wholesaler

Distributes a range of over 14,000 products directly to veterinary practices utilising its own vehicle fleet. NVS supplies pharmaceuticals, pet products, consumables and accessories and has also developed a range of IT solutions for veterinary practices

Dechra Laboratory
Services and Dechra
Specialist Laboratories

Our laboratory businesses are first and second referral providers of histology, pathology, haemotology, chemistry and microbiology services to veterinary practices

Veterinary Practices

Business model

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.